Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
3
×
deals
3
×
life sciences
national blog main
san francisco blog main
akouos
cancer
clinical trials
fda
ipo
national top stories
new york blog main
san diego blog main
san diego top stories
startups
venture capital
abbvie
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
armo biosciences
astellas pharmaceuticals
astrazeneca
autoimmune
avalon ventures
biogen
bluerock therapeutics
boston
boulder/denver blog main
boulder/denver top stories
california institute for biomedical research
cancer immunotherapy
cerovene
coi pharmaceuticals
correlation ventures
covid-19
crispr
What
ipo
plans
3
×
medicines
acquisitions
advance
affects
americans
announced
approved
bio
biology
ceo
collabs
company
covid
cytokine
daniel
date
deal
developing
drug
drugs
enhanced
fda
files
frequency
gilead
gilead’s
hearing
help
initial
introduce
laying
loss
meds
millions
money
month
offering
o’day
Language
unset
Current search:
plans
×
deals
×
" boston blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs